Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
about
Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA alters amyloid-beta productionGGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β productionApolipoprotein E receptors in the nervous systemMild cognitive impairment: pathology and mechanisms.Trafficking regulation of proteins in Alzheimer's diseaseSORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseLoss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's diseaseOmega-3 fatty acids and dementia.U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.Neuronal LR11 expression does not differentiate between clinically-defined Alzheimer's disease and control brainsAlzheimer's disease risk genes and mechanisms of disease pathogenesisThe role of apolipoprotein E in Alzheimer's disease.Meta-analysis of the association between variants in SORL1 and Alzheimer disease.DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effectsGenome-Wide Analyses of Working-Memory Ability: A Review.The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes.Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markersAlzheimer's disease: advances in traffickingGenome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptorsLinking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesisReduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.Impact of SORL1 genetic variations on MRI markers in non-demented elders.Chipping away at diagnostics for neurodegenerative diseasesExpression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.The Role of SORL1 in Alzheimer's Disease.SorLA complement-type repeat domains protect the amyloid precursor protein against processing.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.Unraveling the genes implicated in Alzheimer's disease.Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.SorLA in glia: shared subcellular distribution patterns with caveolin-1
P2860
Q24314744-A27B0D98-0737-4052-B031-3FE43C69014CQ24336029-BA79FDBA-429C-49A4-A98C-7A7F3A798858Q24607165-3FE5C59E-3936-4507-9E06-6F5868E792C3Q24631255-EF4D0EEB-B5BA-4E02-B1E9-7479298E2DC2Q26825722-C4B16C49-8BE8-4B08-A38C-FF7A0060E2B2Q28260619-7DC3E74D-DB89-45DD-8B5C-C3E2F2950932Q28588884-C2B79E94-73D4-45D0-95AD-CA8936280A4AQ33602402-A20059BF-71AE-4D9A-B891-F1D40C96DE17Q33616573-B066CB5A-3EB9-4C28-8A0A-26FA72CEBC8CQ33683437-8F2AEB7B-348A-4964-8A3A-17A2072913EEQ33713286-D68EDCB4-9333-4BE4-96FB-8F0F59144672Q34013606-2DDA7D86-BD26-4A52-904C-664AB46AF054Q34395343-E20345B4-6D53-410A-B3A1-5FEB83E087D1Q34425904-DFE374DA-DFBF-415D-A944-33406B857A08Q34603092-3473C4C1-C75E-4627-BA4A-C65ABA2CC872Q34913294-BD9E5199-EEFA-4487-99F7-2383E30D8C82Q35053868-7EB44F2F-28D5-4242-8043-C0B6A8553700Q35116207-9E375893-810A-43A1-BD45-056F6EF33208Q35186622-06CEA444-BB9E-4EC4-BF9C-88A9ED7E394EQ35743094-EBF596A1-1882-47AD-A3F3-A32BB16E7D9DQ36616575-CB742940-1015-405C-BE40-7EA75CF45D4FQ36622813-9378A684-3F67-4643-87C1-AB2DD6611DE8Q36966070-6DCB8C5D-21AC-4F3D-A2AB-C9CD449BD73FQ37037913-813215EB-18B6-47C7-BFBC-E9E506143804Q37156208-29F513D3-B444-47A3-9F7E-7319528215C9Q37174236-96DC162B-ECAF-477E-8B97-2128322A6B06Q37336139-8475CF97-4691-495F-B8CD-3FB4E40C2848Q37343839-C15AE8CF-7CE6-4FC5-8095-CD79C7A495BDQ37362490-DF8B52C4-18E6-4B0C-8B15-541797C2021AQ37366183-7E9BBAD1-30EF-499F-9CE6-9FE9E1F87C25Q37418341-E40A4EAF-0306-48E1-BC4D-AB9DBE03A2F6Q37732481-B9EFC75F-1252-437F-92CF-B52567FEAA44Q37772498-90EE2327-CF7D-4CB2-B7C3-4C4FB7B4F376Q37999105-CF734DBA-90D9-4AA8-AF95-0A4326C6A520Q38212198-34273088-BEE6-49ED-BD21-DD9031E56EF7Q38926992-BBFDF524-431B-461B-9A19-A7953387E9BEQ39135845-DAC0D26F-2710-46F9-9D2B-8960DF3CB444Q41116769-08067985-F11D-4E1A-B570-D89E84BDEB84Q41381112-479E1C8F-CEAE-4233-B61E-89E6DE7DE6CEQ42122534-412DD2C3-D255-4211-A2AF-3C856017884A
P2860
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
@en
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.
@nl
type
label
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
@en
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.
@nl
prefLabel
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
@en
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.
@nl
P2093
P2860
P356
P1433
P1476
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
@en
P2093
Allan I Levey
Elliott J Mufson
Howard D Rees
James J Lah
Joanne Wuu
Kristen L Sager
Marla Gearing
Susan E Leurgans
P2860
P304
P356
10.1002/ANA.21190
P577
2007-12-01T00:00:00Z